Relation of multiple inflammatory biomarkers to incident atrial fibrillation.
about
EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseasesAssociation of sex hormones, aging, and atrial fibrillation in men: the Framingham Heart Study.Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants.Body mass index and risk of left atrial thrombus in patients with atrial fibrillation.A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in womenB-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.The expression levels of plasma micoRNAs in atrial fibrillation patients.Multiple biomarkers and atrial fibrillation in the general populationMeta-analysis of genome-wide association studies identifies two loci associated with circulating osteoprotegerin levelsMultiple inflammatory biomarker detection in a prospective cohort study: a cross-validation between well-established single-biomarker techniques and an electrochemiluminescense-based multi-array platformDepression in atrial fibrillation in the general population.New-onset atrial fibrillation after acute myocardial infarction and its relation to admission biomarkers (from the TRIUMPH registry).Effects of body mass index on risks for ischemic stroke, thromboembolism, and mortality in Chinese atrial fibrillation patients: a single-center experience.Atrial fibrillation: current knowledge and future directions in epidemiology and genomics.Large-scale candidate gene analysis in whites and African Americans identifies IL6R polymorphism in relation to atrial fibrillation: the National Heart, Lung, and Blood Institute's Candidate Gene Association Resource (CARe) project.Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013.Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.Predictors of atrial fibrillation recurrence after cryoballoon ablation.Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes.Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation.Excavatolide B Modulates the Electrophysiological Characteristics and Calcium Homeostasis of Atrial Myocytes.Atrial Fibrillation and Declining Physical Performance in Older Adults: The Health, Aging, and Body Composition Study.Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study.Elevated plasma levels of Th17-related cytokines are associated with increased risk of atrial fibrillationCirculating Biomarkers Predictive of Postoperative Atrial Fibrillation.The risk of atrial fibrillation in patients with rheumatoid arthritisTargeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins.Biomarkers in atrial fibrillation: a clinical review.Biomarkers in atrial fibrillation: an overview.Cardioembolic stroke diagnosis using blood biomarkers.Inflammation and the pathogenesis of atrial fibrillation.CHA2DS2-VASc Score: A Predictor of Thromboembolic Events and Mortality in Patients With an Implantable Monitoring Device Without Atrial Fibrillation.Role of tumor necrosis factor alpha in the pathogenesis of atrial fibrillation: A novel potential therapeutic target?Association Between Vascular Cell Adhesion Molecule 1 and Atrial Fibrillation.Associations of Abdominal Obesity and New-Onset Atrial Fibrillation in the General Population.Characteristics of PR interval as predictor for atrial fibrillation: association with biomarkers and outcomes.Atrial fibrillation, cognition and dementia: A review.Relations of Liver Fat With Prevalent and Incident Atrial Fibrillation in the Framingham Heart Study.Risk factors responsible for atrial fibrillation development between symptomatic patients with concealed or manifest atrioventricular accessory pathways.
P2860
Q30375302-EBDE78EE-10CF-4624-958C-2318B1B00B16Q30419941-25F492AC-3AE3-479E-AC90-6820F5DA776EQ33668906-3B008E92-1FC5-4FDF-A568-8EFA81B737B7Q33721705-5149FC52-82FD-4A41-9A09-8F33BC9C3A2EQ33951474-EE96A868-414A-43E6-9F5C-731963AD8F3FQ33992740-9A577636-4763-483B-8B30-6AAA31E43DF1Q34342621-76A76DC0-CDC0-4ACA-8823-E17DBAE1E2AFQ34427635-F9557D9A-395C-4861-B85F-CF0D5448A819Q34525092-E5EE21EA-563F-483A-83A7-432AD38793E5Q34555532-070B18BD-DDAA-4788-BD11-A5F743035B8BQ34615040-5DC89ED4-0F7D-4B47-8C9F-089222A2FAFCQ35063678-C11BF199-C605-401B-AEC0-78E386274296Q35068612-2FD528EA-805D-4E32-80AB-6183840F347DQ35305757-B2DAEAE1-C49F-40FA-9741-BFCA9B317B62Q35526930-1D867342-29EC-46B6-A6D2-49CFE23B8E49Q35575039-707A91E2-A0DA-41D5-894A-6B9A42F8DB6EQ35585789-C46B4A05-4284-4798-B14B-C8A0BE146861Q35609742-086EC9A6-1DDF-4B58-9951-D9B1898575E7Q35821956-1825B072-A375-4987-A169-A9C049253331Q35926521-51703AC5-14F6-464F-B0C8-D28F929501FDQ36172879-79D86132-7E8F-4CB5-B803-E22287777548Q36260790-B17696EA-149B-4249-99EB-4F85137C987BQ36784212-3E3D6C35-76A6-405C-BBF6-98DB4CF9673CQ36833592-CD6ADC8A-3399-413D-B51C-2B136D14926FQ36919277-85D676EA-6148-48DC-8B0F-24565BB052D2Q37094015-FE81D693-7169-49C6-A352-C40F58C2BB60Q37446317-5D2C3969-4B14-4C4F-9F4F-058C23FDE527Q37602866-6C2F1ED6-5BB3-4B7A-9EB6-1EC7FC4C5BCDQ38079565-02E73FF8-B39B-4E3A-8BB2-F309A7A4FF24Q38174213-79DDC110-6A25-4C3F-9766-55D25E7A2D7EQ38188010-EAC2F015-6505-4E50-A241-D3C2C057748AQ38333088-A220FBB2-534A-4AD6-A882-A2ED5738BE05Q38372615-2EB39ACC-6B72-4C76-861A-0524ED662EC8Q38486305-8D6FEBA6-D703-497E-8825-C51F71A55E41Q38738095-DBA95ED2-AB27-4153-A352-75EBA841EF2EQ38739817-D9AE6968-E59B-4987-95ED-574BB1247832Q39223539-08751FAF-2C29-4D8C-A4C4-C35F7C65134AQ39343435-821C506D-9FC9-4C20-868D-D602ECB5D5B3Q40218239-0975E773-BAAD-4FDE-8179-B8203B7D02F3Q40964057-A64B5B15-84FE-441A-8305-B5308FBF8AE9
P2860
Relation of multiple inflammatory biomarkers to incident atrial fibrillation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Relation of multiple inflammatory biomarkers to incident atrial fibrillation.
@ast
Relation of multiple inflammatory biomarkers to incident atrial fibrillation.
@en
Relation of multiple inflammatory biomarkers to incident atrial fibrillation.
@nl
type
label
Relation of multiple inflammatory biomarkers to incident atrial fibrillation.
@ast
Relation of multiple inflammatory biomarkers to incident atrial fibrillation.
@en
Relation of multiple inflammatory biomarkers to incident atrial fibrillation.
@nl
prefLabel
Relation of multiple inflammatory biomarkers to incident atrial fibrillation.
@ast
Relation of multiple inflammatory biomarkers to incident atrial fibrillation.
@en
Relation of multiple inflammatory biomarkers to incident atrial fibrillation.
@nl
P2093
P2860
P50
P921
P1476
Relation of multiple inflammatory biomarkers to incident atrial fibrillation.
@en
P2093
Daniel Levy
Jennifer F Yamamoto
John F Keaney
Renate B Schnabel
Thomas J Wang
P2860
P356
10.1016/J.AMJCARD.2009.02.053
P407
P577
2009-05-04T00:00:00Z